Case Studies
Norlase is a pioneering and ground-breaking Danish technology business with global growth potential
Norlase
Norlase is a Danish technology business that has produced a patented and low cost laser system which is used in ophthalmic and dermatological treatments, a $3billion per annum global market.
The Company’s flagship LEAF photocoagulator device is a highly innovative laser system that is ultra-portable, 10x more efficient, 90% smaller and 70% cheaper and 60% cheaper to purchase than antiquated comparable products that have been widely used for decades.
Norlase are developing a suite a leading-edge laser devices that utilise their patented and low cost technology and each of these devices exhibit similar attributes to their LEAF and LION products.
The Company has achieved numerous key milestones, bringing to market revolutionary laser medical products and achieving traction internationally.
Norlase looks well positioned to pick up market share from the incumbent providers of the bulky, box-like and expensive systems that have been widely deployed for decades.
-
Capital Raised
£21m equity
-
Investors
HNWI, Family offices, Directors, Principals of West Hill